Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN D JEPPSON

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1417943622
CMS profile
660062
Location
BOISE, ID

General Payments · PY2018–2024

$77,211.67

  • Reported across 405 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,422.70

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,664.74 70
PY2019 $16,464.47 59
PY2020 $2,168.02 42
PY2021 $6,985.90 60
PY2022 $20,610.99 73
PY2023 $15,894.85 69
PY2024 $2,422.70 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $119.45 04/03/2024 Food and Beverage Undisputed 01/23/2026 1111609415 CMS
AstraZeneca Pharmaceuticals LP $24.43 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105783230 CMS
AstraZeneca Pharmaceuticals LP $53.73 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105319449 CMS
AstraZeneca Pharmaceuticals LP $23.04 02/08/2024 Food and Beverage Undisputed 01/23/2026 1104334718 CMS
AstraZeneca Pharmaceuticals LP $18.67 02/26/2024 Food and Beverage Undisputed 01/23/2026 1104394461 CMS
AstraZeneca Pharmaceuticals LP $600.00 03/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105520631 CMS
AstraZeneca Pharmaceuticals LP $16.32 03/25/2024 Food and Beverage Undisputed 01/23/2026 1104691834 CMS
AstraZeneca Pharmaceuticals LP $29.65 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104564230 CMS
AstraZeneca Pharmaceuticals LP $21.08 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105456216 CMS
AstraZeneca Pharmaceuticals LP $22.04 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104681569 CMS
AstraZeneca Pharmaceuticals LP $250.00 07/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104304298 CMS
AstraZeneca Pharmaceuticals LP $125.00 07/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105842113 CMS
AstraZeneca Pharmaceuticals LP $38.88 07/20/2024 Food and Beverage Undisputed 01/23/2026 1105276342 CMS
AstraZeneca Pharmaceuticals LP $600.00 10/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104213183 CMS
BioCryst US Sales Co., LLC $19.32 02/16/2024 Food and Beverage Undisputed 01/23/2026 1117469401 CMS
Blueprint Medicines Corporation $18.35 01/24/2024 Food and Beverage Undisputed 01/23/2026 1147456649 CMS
Blueprint Medicines Corporation $28.19 04/18/2024 Food and Beverage Undisputed 01/23/2026 1147456701 CMS
Blueprint Medicines Corporation $46.98 07/19/2024 Food and Beverage Undisputed 01/23/2026 1147456829 CMS
CSL Behring $27.61 05/24/2024 Food and Beverage Undisputed 01/23/2026 1134608801 CMS
Genentech USA, Inc. $30.13 04/03/2024 Food and Beverage Undisputed 01/23/2026 1133035166 CMS
Genentech USA, Inc. $14.90 05/21/2024 Food and Beverage Undisputed 01/23/2026 1133035170 CMS
GENZYME CORPORATION $8.32 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139608378 CMS
GENZYME CORPORATION $125.78 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139608446 CMS
GENZYME CORPORATION $5.19 04/02/2024 Food and Beverage Undisputed 01/23/2026 1139608394 CMS
GlaxoSmithKline, LLC. $14.09 02/07/2024 Food and Beverage Undisputed 01/23/2026 1116510519 CMS
GlaxoSmithKline, LLC. $19.29 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116581109 CMS
Grifols USA, LLC $21.35 05/13/2024 Food and Beverage Undisputed 01/23/2026 1124735249 CMS
Grifols USA, LLC $24.04 05/17/2024 Food and Beverage Undisputed 01/23/2026 1124735251 CMS
PFIZER INC. $14.53 01/22/2024 Food and Beverage Undisputed 01/23/2026 1131530871 CMS
Regeneron Healthcare Solutions, Inc. $23.06 02/14/2024 Food and Beverage Undisputed 01/23/2026 1114077986 CMS
Regeneron Healthcare Solutions, Inc. $16.29 04/22/2024 Food and Beverage Undisputed 01/23/2026 1114077988 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.99 03/06/2024 Food and Beverage Undisputed 01/23/2026 1137589088 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.